Gene expression profiling in dermatitis herpetiformis skin lesions

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Dolcino, M ^a   Cozzani, E ^b   Riva, S ^b   Parodi, A ^b   Tinazzi, E ^c   Lunardi, C ^c   Puccetti, A ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; MATRIX METALLOPROTEINASE; PEPTIDE HYDROLASE;

ADAM19 GENE; ADAM9 GENE; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BASP1 GENE; BDKRD2 GENE; BLISTER; CCL5 GENE; CELIAC DISEASE; CELL ACTIVATION; CELL GROWTH; CELLULAR IMMUNITY; CGREF1 GENE; CLINICAL ARTICLE; CMA1 GENE; CONTROLLED STUDY; CPA3 GENE; CTSG GENE; DERMATITIS HERPETIFORMIS; DERMOEPIDERMAL JUNCTION; DNA MICROARRAY; DOWN REGULATION; DPP4 GENE; ELA2 GENE; ENDOTHELIUM CELL; ENPP2 GENE; EXTRAVASATION; FAS GENE; FEMALE; FSTL1 GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IFI16 GENE; IL8 GENE; INFLAMMATION; ITGB4 GENE; LAG3 GENE; LAMA5 GENE; LEUKOCYTE; MALE; MMP9 GENE; NAMPT GENE; NEUTROPHIL; NT5E GENE; NUCLEOTIDE SEQUENCE; PA2G4 GENE; PATHOGENESIS; PLEC1 GENE; PPP2R1B GENE; PRIORITY JOURNAL; PTGFR GENE; SELE GENE; SELL GENE; SKIN BIOPSY; TNFSF10 GENE; TPSB2 GENE; TRAF5 GENE; UNINDEXED SEQUENCE; UPREGULATION; APOPTOSIS; B LYMPHOCYTE; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN; T LYMPHOCYTE;

ADULT; APOPTOSIS; B-LYMPHOCYTES; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; DERMATITIS HERPETIFORMIS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEUTROPHILS; PEPTIDE HYDROLASES; SKIN; T-LYMPHOCYTES;

EID: 84866980334     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/198956     Document Type: Article

References (49)

1. árpáti S. K., Dermatitis herpetiformis. Clinics in Dermatology 2012 30 1 56 59
2. Bolotin D., Petronic-Rosic V., Dermatitis herpetiformis: part I. Epidemiology, pathogenesis, and clinical presentation. Journal of the American Academy of Dermatology 2011 64 6 1017 1024 2-s2.0-79956154255 10.1016/j.jaad.2010.09.777
3. Bolotin D., Petronic-Rosic V., Dermatitis herpetiformis: part II. Diagnosis, management, and prognosis. Journal of the American Academy of Dermatology 2011 64 6 1027 1033 2-s2.0-79956126241 10.1016/j.jaad.2010.09.776
4. Sárdy M., Kárpáti S., Merkl B., Paulsson M., Smyth N., Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. Journal of Experimental Medicine 2002 195 6 747 757 2-s2.0-0037128650 10.1084/jem.20011299 (Pubitemid 34259719)
5. Fry L., Dermatitis herpetiformis: problems, progress and prospects. European Journal of Dermatology 2002 12 6 523 531 2-s2.0-0036862282 (Pubitemid 35440786)
6. Oberhuber G., Granditsch G., Vogelsang H., The histopathology of coeliac disease: time for a standardized report scheme for pathologists. European Journal of Gastroenterology and Hepatology 1999 11 10 1185 1194 2-s2.0-0033364256 (Pubitemid 30433773)
7. Triebel F., LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends in Immunology 2003 24 12 619 622 2-s2.0-0344440962 10.1016/j.it.2003.10.001 (Pubitemid 37485908)
8. Miyagaki T., Sugaya M., Suga H., Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels. Journal of the European Academy of Dermatology and Venereology, 2011. In press 10.1111/j.1468-3083.2011.04340.x
9. Ålgars A., Karikoski M., Yegutkin G. G., Stoitzner P., Niemelä J., Salmi M., Jalkanen S., Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 2011 117 16 4387 4393 2-s2.0-79955944679 10.1182/blood-2010-11-321646
10. Rice G. I., Bond J., Asipu A., Brunette R. L., Manfield I. W., Carr I. M., Fuller J. C., Jackson R. M., Lamb T., Briggs T. A., Ali M., Gornall H., Couthard L. R., Aeby A., Attard-Montalto S. P., Bertini E., Bodemer C., Brockmann K., Brueton L. A., Corry P. C., Desguerre I., Fazzi E., Cazorla A. G., Gener B., Hamel B. C. J., Heiberg A., Hunter M., Van Der Knaap M. S., Kumar R., Lagae L., Landrieu P. G., Lourenco C. M., Marom D., McDermott M. F., Van Der Merwe W., Orcesi S., Prendiville J. S., Rasmussen M., Shalev S. A., Soler D. M., Shinawi M., Spiegel R., Tan T. Y., Vanderver A., Wakeling E. L., Wassmer E., Whittaker E., Lebon P., Stetson D. B., Bonthron D. T., Crow Y. J., Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nature Genetics 2009 41 7 829 832 2-s2.0-67649861901 10.1038/ng.373
11. Gronert K., Kantarci A., Levy B. D., Clish C. B., Odparlik S., Hasturk H., Badwey J. A., Colgan S. P., Van Dyke T. E., Serhan C. N., A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. Journal of Immunology 2004 172 3 1856 1861 2-s2.0-9144251640 (Pubitemid 38116835)
12. Bukau B., Weissman J., Horwich A., Molecular chaperones and protein quality control. Cell 2006 125 3 443 451 2-s2.0-33646127577 10.1016/j.cell.2006. 04.014
13. Rosebeck S., Leaman D. W., Mitochondrial localization and pro-apoptotic effects of the interferon-inducible protein ISG12a. Apoptosis 2008 13 4 562 572 2-s2.0-41149134240 10.1007/s10495-008-0190-0
14. Liu Z., Oh S. M., Okada M., Liu X., Cheng D., Peng J., Brat D. J., Sun S. Y., Zhou W., Gu W., Ye K., Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. Molecular Biology of the Cell 2009 20 3 757 768 2-s2.0-64049118773 10.1091/mbc.E08-09-0983
15. Tammi R. H., Passi A. G., Rilla K., Karousou E., Vigetti D., Makkonen K., Tammi M. I., Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS Journal 2011 278 9 1419 1428 2-s2.0-79955052019 10.1111/j.1742-4658.2011.08070.x
16. Hasegawa K., Yoneda M., Kuwabara H., Miyaishi O., Itano N., Ohno A., Zako M., Isogai Z., Versican, a major hyaluronan-binding component in the dermis, loses its hyaluronan-binding ability in solar elastosis. Journal of Investigative Dermatology 2007 127 7 1657 1663 2-s2.0-34250667912 10.1038/sj.jid.5700754 (Pubitemid 46933404)
17. Airola K., Vaalamo M., Reunala T., Saarialho-Kere U. K., Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis. Journal of Investigative Dermatology 1995 105 2 184 189 2-s2.0-0029131341
18. Airola K., Reunala T., Salo S., Saarialho-Kere U. K., Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions. Journal of Investigative Dermatology 1997 108 1 7 11 2-s2.0-0031024349 (Pubitemid 27019835)
19. Koster J., Geerts D., Favre B., Borradori L., Sonnenberg A., Analysis of the interactions between BP180, BP230, plectin and the integrin α 6 β 4 important for hemidesmosome assembly. Journal of Cell Science 2003 116 2 387 399 2-s2.0-0037439896 10.1242/jcs.00241 (Pubitemid 36163879)
20. Bettini M., Szymczak-Workman A. L., Forbes K., Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3. Journal of Immunology 2011 187 7 3493 3498
21. Okazaki T., Okazaki I. M., Wang J., Sugiura D., Nakaki F., Yoshida T., Kato Y., Fagarasan S., Muramatsu M., Eto T., Hioki K., Honjo T., PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice. Journal of Experimental Medicine 2011 208 2 395 407 2-s2.0-79951684125 10.1084/jem.20100466
22. Sponza S., De Andrea M., Mondini M., Gugliesi F., Gariglio M., Landolfo S., Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF- α Cellular Immunology 2009 257 1-2 55 60 2-s2.0-65049087496 10.1016/j.cellimm.2009.02.007
23. Miyamae T., Marinov A. D., Sowders D., Wilson D. C., Devlin J., Boudreau R., Robbins P., Hirsch R., Follistatin-like protein-1 is a novel proinflammatory molecule. Journal of Immunology 2006 177 7 4758 4762 2-s2.0-33749131747 (Pubitemid 44469810)
24. Clutter S. D., Wilson D. C., Marinov A. D., Hirsch R., Follistatin-like protein 1 promotes arthritis by up-regulating IFN- γ Journal of Immunology 2009 182 1 234 239 2-s2.0-59849104826
25. Forstrom L., Reunala T., Vapaatalo H., Linden I. B., Increased suction blister concentrations of prostaglandin E and F(2 α) in dermatitis herpetiformis. Acta Dermato-Venereologica 1979 59 5 458 460 2-s2.0-0018698702 (Pubitemid 10249032)
26. Shaw O. M., Harper J. L., Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis. Biochemical Biophysical Research Communications 2011 416 3-4 266 269
27. Hall R. P. III, Benbenisty K. M., Mickle C., Takeuchi F., Streilein R. D., Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. Journal of Investigative Dermatology 2007 127 9 2158 2165 2-s2.0-34547892654 10.1038/sj.jid.5700929 (Pubitemid 47258500)
28. Hall R. P. III, Takeuchi F., Benbenisty K. M., Streilein R. D., Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-selectin, and TNF- α Journal of Investigative Dermatology 2006 126 6 1331 1337 2-s2.0-33745516897 10.1038/sj.jid.5700277 (Pubitemid 43997916)
29. Li A., Varney M. L., Valasek J., Godfrey M., Dave B. J., Singh R. K., Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 2005 8 1 63 71 2-s2.0-24044522259 10.1007/s10456-005-5208-4 (Pubitemid 41223840)
30. Gabel C. A., P2 purinergic receptor modulation of cytokine production. Purinergic Signalling 2007 3 1-2 27 38 2-s2.0-33947675761 10.1007/s11302-006- 9034-y
31. Cotran R. S., Gimbrone M. A., Bevilacqua M. P., Induction and detection of a human endothelial activation antigen in vivo. Journal of Experimental Medicine 1986 164 2 661 666 2-s2.0-0022484015 (Pubitemid 16050709)
32. Lawrence M. B., Springer T. A., Neutrophils roll on E-selectin. Journal of Immunology 1993 151 11 6338 6346 2-s2.0-0027453990 (Pubitemid 23340380)
33. Kannan S., Neutrophil chemotaxis: autotaxin induced attenuation of purine/pyrimidine signaling precede the overexpression of integrin(s). Medical Hypotheses 2005 65 1 197 198 2-s2.0-18944391137 10.1016/j.mehy.2005.01.001 (Pubitemid 40704557)
34. Niemann C. U., Åbrink M., Pejler G., Fischer R. L., Christensen E. I., Knight S. D., Borregaard N., Neutrophil elastase depends on serglycin proteoglycan for localization in granules. Blood 2007 109 10 4478 4486 2-s2.0-34248398513 10.1182/blood-2006-02-001719 (Pubitemid 46743418)
35. Noma H., Kato T., Fujita H., Kitagawa M., Yamano T., Kitagawa S., Calpain inhibition induces activation of the distinct signalling pathways and cell migration in human monocytes. Immunology 2009 128 1, part 2 e487 e496 2-s2.0-68249135245 10.1111/j.1365-2567.2008.03012.x
36. Caproni M., Torchia D., Antiga E., Degl'Innocenti D., Barletta E., Baroni G., Santucci M., Fabbri P., The role of apoptosis in the pathogenesis of dermatitis herpetiformis. International Journal of Immunopathology and Pharmacology 2005 18 4 691 699 2-s2.0-33644863894
37. Bosch X., Systemic lupus erythematosus and the neutrophil. The New England Journal of Medicine 2011 365 8 758 760
38. Halagovec A., Héjj F., Baranová Z., Fibronectin, interstitial collagens and type IV collagen in dermatitis herpetiformis. Casopís Lékarů Ceskch 1996 135 9 273 276 2-s2.0-18344417146
39. Karpati S., Meurer M., Stolz W., Schrallhammer K., Krieg T., Braun-Falco O., Dermatitis herpetiformis bodies: ultrastructural study on the skin of patients using direct preembedding immunogold labeling. Archives of Dermatology 1990 126 11 1469 1474 2-s2.0-0025077505 10.1001/archderm.126.11.1469 (Pubitemid 20367682)
40. Reunala T. L., Dermatitis herpetiformis. Clinics in Dermatology 2001 19 6 728 736 2-s2.0-0034760869 10.1016/S0738-081X(00)00184-X (Pubitemid 33035022)
41. Zhao M., Trimbeger M. E., Li N., Diaz L. A., Shapiro S. D., Liu Z., Role of FcRs in animal model of autoimmune bullous pemphigoid. Journal of Immunology 2006 177 5 3398 3405 2-s2.0-33747801066 (Pubitemid 44277860)
42. Oikarinen A. I., Reunala T., Zone J. J., Proteolytic enzymes in blister fluids from patients with dermatitis herpetiformis. British Journal of Dermatology 1986 114 3 295 302 2-s2.0-0022634705 (Pubitemid 16124173)
43. Gornowicz-Porowska J., Bowszyc-Dmochowska M., Dmochowski M., Autoimmunity-driven enzymatic remodeling of the dermal-epidermal junction in bullous pemphigoid and dermatitis herpetiformis. Autoimmunity 2012 45 1 71 80
44. Salmela M. T., Pender S. L. F., Reunala T., Macdonald T., Saarialho-Kere U., Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut 2001 48 4 496 502 2-s2.0-0035080043 10.1136/gut.48.4.496 (Pubitemid 32234793)
45. Zebrowska A., Narbutt J., Sysa-Jedrzejowska A., Kobos J., Waszczykowska E., The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediators of Inflammation 2005 2005 6 373 379 2-s2.0-29144519351 10.1155/MI.2005.373 (Pubitemid 41803406)
46. Kellouche S., Mourah S., Bonnefoy A., Schoëvaert D., Podgorniak M. P., Calvo F., Hoylaerts M. F., Legrand C., Dosquet C., Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation. Experimental Cell Research 2007 313 3 486 499 2-s2.0-33846813532 10.1016/j.yexcr.2006.10.023 (Pubitemid 46201809)
47. Martínez-Hernández M. G., Baiza-Gutman L. A., Castillo-Trápala A., Armant D. R., Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9. Reproduction 2011 141 2 227 239 2-s2.0-78951470297 10.1530/REP-10-0334
48. Leivo T., Lohi J., Kariniemi A. L., Molander G., Kiraly C. L., Kotovirta M. L., Owaribe K., Burgeson R. E., Leivo I., Hemidesmosomal molecular changes in dermatitis herpetiformis; decreased expression of BP230 and plectin/HD1 in uninvolved skin. Histochemical Journal 1999 31 2 109 116 2-s2.0-0033011887 10.1023/A:1003465820962 (Pubitemid 29294799)
49. Hashmi S., Marinkovich M. P., Molecular organization of the basement membrane zone. Clinics in Dermatology 2011 29 4 398 411 2-s2.0-79958826438 10.1016/j.clindermatol.2011.01.009